The combination of cytomorphology and FCIP permits the diagnosis with a high degree of certainty; however, distinction from APL mimics (e.g., NPM1-mutated, other AML with monocytic differentiation, KMT2A-rearranged AML) can be challenging. The gene discussed is KMT2A; the disease is acute myeloid leukemia.